Clinical Trials Directory

Trials / Unknown

UnknownNCT00790465

Efficacy of Dark Chocolate in Achalasia Patients

Efficacy of Dark Chocolate in Achalasia Patients: Placebo-Controlled Study

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Flavanols, present in dark chocolate, were shown to induce Nitric Oxide synthesis. Since Nitric Oxide facilitates smooth muscle relaxation, it might ease the relaxation of the LES (lower esophageal sphincter)as well. The objective of the present study is to evaluate tha efficacy of dark chocolate in improving LES relaxation in achalasia patients.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTdark chocolate21 g/d of dark chocolate for 2 weeks (7 g. before each meal). 7 grams of dark chocolate at day 1 during manometry.
DIETARY_SUPPLEMENTplacebo chocolate with crossover to dark chocolatePlacebo at day 1 during manometry, and than crossover to dark chocolate for 2 weeks treatment.

Timeline

Start date
2008-11-01
Primary completion
2009-11-01
Completion
2010-11-01
First posted
2008-11-13
Last updated
2008-11-13

Source: ClinicalTrials.gov record NCT00790465. Inclusion in this directory is not an endorsement.

Efficacy of Dark Chocolate in Achalasia Patients (NCT00790465) · Clinical Trials Directory